PDMR Dealings & Shareholding Update

AI SummaryClose X

Allergy Therapeutics plc announced a reorganisation within ZQ Group involving the transfer of shares between entities, which did not alter the ultimate beneficial ownership. Separately, SkyGem International Holdings Limited placed 209,600,000 shares at an average price of 10 pence per share to four investors, with these shares restricted from AIM market trading for twelve months, a move intended to optimise the shareholder base ahead of a potential dual listing in Hong Kong. Following these transactions, ZQ Capital and related entities hold 3,831,131,532 shares, representing 60.5% of the company's issued share capital.

Disclaimer*

UK 100

Latest directors dealings